InsiderLens
All transactionsBrowse millions of insider transactions
Top buysLargest insider purchases
Top sellsLargest insider sales
Cluster activityMultiple insiders trading together
All companiesBrowse all 22,000+ companies
ScreenerFilter by sector, country, activity
By countryBrowse by market
All InsidersBrowse all 240,000+ Insiders
Most activeInsiders with the most trades
Best performersHighest returns on insider buys
Alerts

Global search

Find a company or insider, or run a shortcut.

InsiderLens

Track insider trading activity, analyze financial data, and monitor insider transactions across global markets.

Transactions

  • Top buys
  • Top sells
  • Companies
  • Insiders
  • Screener

Resources

  • API
  • Blog
  • Help center
  • Methodology

Company

  • About
  • Contact
  • Privacy policy
  • Terms of service
  • Cookie policy

Data sources: SEC EDGAR (US) · AMF / BDIF (FR) · BaFin (DE) · FCA (GB) · FSMA (BE) · AFM (NL) · CNMV (ES) · SIX (CH) · FI (SE) · Oslo Børs (NO) · Nasdaq Nordic & Baltic · and 20+ other European regulators.

The information provided on InsiderLens is for informational purposes only and does not constitute financial advice, investment recommendations, or an offer to buy or sell securities. Insider transaction data is sourced from public regulatory filings. Past insider transactions do not guarantee future performance. Always consult a qualified financial advisor before making investment decisions.

© 2026 InsiderLens

  1. Home
  2. /
  3. Insiders
  4. /
  5. GLASSPOOL JOHN

GLASSPOOL JOHN

BalancedInformative
BoardRELMADA THERAPEUTICS, INC.·OfficerBaxalta IncCIK 0001644079
32 transactions·2 companies·Last Dec 12, 2025
$00 buys
$00 sells
50%/50%164K shares held ≈ $1.2M
BOARD MEMBERatRELMADA THERAPEUTICS, INC.RLMD

Last filing: Apr 2026

OFFICERatBaxalta IncBXLT

Last filing: Mar 2026

Also at RELMADA THERAPEUTICS, INC.

TS
TRAVERSA SERGIO
CEO97 tx
SM
Shenouda Maged
CFO66 tx
EC
Ence Chuck
CFO17 tx
BD
BECK DOUGLAS
CFO15 tx
KE
Kelly Paul Edward
C SUITE76 tx

Insider transactions by GLASSPOOL JOHN

32 transactions — - in purchases, - in sales

DateViaCompanyTypeSharesValue
Dec 12, 25DirectRLMDRELMADA THERAPEUTICS, INC.Grant164 000-
Jun 26, 25DirectRLMDRELMADA THERAPEUTICS, INC.Grant100 000-
May 24, 24DirectRLMDRELMADA THERAPEUTICS, INC.Other20 976-
May 24, 24DirectRLMDRELMADA THERAPEUTICS, INC.Grant20 976-
Dec 15, 23DirectRLMDRELMADA THERAPEUTICS, INC.Grant31 522-
May 25, 23DirectRLMDRELMADA THERAPEUTICS, INC.Grant92 958-
May 25, 22DirectRLMDRELMADA THERAPEUTICS, INC.Grant91 235-
Dec 17, 21DirectRLMDRELMADA THERAPEUTICS, INC.Grant58 765-
Jan 7, 21DirectRLMDRELMADA THERAPEUTICS, INC.Grant100 000-
Jun 3, 16DirectBXLTBaxalta IncDisposition23 447-
Jun 3, 16DirectBXLTBaxalta IncDisposition55 104-
Jun 3, 16DirectBXLTBaxalta IncDisposition10 000-
Jun 3, 16DirectBXLTBaxalta IncDisposition14 274-
Jun 3, 16DirectBXLTBaxalta IncDisposition15 929-
Jun 3, 16DirectBXLTBaxalta IncGrant1 461-
Jun 3, 16DirectBXLTBaxalta IncDisposition41 099-
Mar 7, 16DirectBXLTBaxalta IncOther154$6 120
Mar 4, 16DirectBXLTBaxalta IncOther161$6 355
Mar 3, 16DirectBXLTBaxalta IncGrant15 259-
Mar 3, 16DirectBXLTBaxalta IncOther859$33 759
Feb 15, 16DirectBXLTBaxalta IncGrant258-
Feb 15, 16DirectBXLTBaxalta IncGrant305-
Feb 15, 16DirectBXLTBaxalta IncOther353$13 767
Aug 11, 15DirectBXLTBaxalta IncGrant80-
Aug 11, 15DirectBXLTBaxalta IncGrant75-
Jul 1, 15DirectBXLTBaxalta IncGrant23 477-
Jul 1, 15DirectBXLTBaxalta IncOther55 104-
Jul 1, 15DirectBXLTBaxalta IncOther15 929-
Jul 1, 15DirectBXLTBaxalta IncOther14 274-
Jul 1, 15DirectBXLTBaxalta IncOther10 000-
Showing 30 most recent transactions
Direct = personal transaction
Via entity / trust / associate

Frequently asked questions about GLASSPOOL JOHN

What are GLASSPOOL JOHN's recent insider transactions?

GLASSPOOL JOHN has filed 32 insider transactions across 2 companies, totaling $0 in purchases and $0 in sales. The most recent filing was on December 12, 2025.

Is GLASSPOOL JOHN a net buyer or seller of shares?

Based on regulatory disclosures, GLASSPOOL JOHN is a net seller with 0 purchases and 0 sales on record.

Data sourced from public regulatory filings (SEC EDGAR, AMF, BaFin). This information is provided for educational purposes and does not constitute investment advice, a recommendation, or a solicitation to buy or sell securities.

Updated December 12, 2025·Full disclaimer